Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.366
+0.005 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
0.364
-0.001 (-0.33%)
Pre-market: Mar 10, 2026, 5:35 AM EDT
Calidi Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 22 | 54 | 100 | 282 | - |
| Market Cap Growth | -90.48% | -58.52% | -46.69% | -64.38% | - | - |
| Enterprise Value | -4 | 30 | 53 | - | - | - |
| Last Close Price | 0.37 | 13.80 | 181.21 | 1220.45 | 1177.25 | - |
| PS Ratio | - | - | - | 2232.42 | 628.14 | - |
| PB Ratio | 0.37 | 11.29 | -6.50 | -2.46 | -12.47 | - |
| P/TBV Ratio | 0.43 | 14.48 | - | - | - | - |
| Debt / Equity Ratio | 0.46 | 3.58 | -0.88 | -0.15 | -0.23 | -0.87 |
| Net Debt / Equity Ratio | -0.98 | -1.30 | -0.64 | -0.14 | -0.13 | -0.84 |
| Net Debt / EBITDA Ratio | 0.37 | 0.12 | -0.18 | -0.25 | -0.32 | -1.69 |
| Net Debt / FCF Ratio | 0.33 | 0.13 | -0.19 | -0.41 | -0.38 | -2.18 |
| Asset Turnover | - | - | - | 0.02 | 0.17 | - |
| Quick Ratio | 2.00 | 1.01 | 0.19 | 0.01 | 0.08 | 0.05 |
| Current Ratio | 2.12 | 1.08 | 0.42 | 0.02 | 0.11 | 0.06 |
| Return on Assets (ROA) | -119.65% | -112.47% | -287.25% | -482.80% | -229.02% | - |
| Return on Capital Employed (ROCE) | -224.10% | -464.70% | 13611.30% | 57.30% | 42.60% | 96.30% |
| Earnings Yield | -868.52% | -99.68% | -54.56% | -25.31% | -3.88% | - |
| FCF Yield | -737.94% | -88.73% | -51.48% | -13.58% | -2.83% | - |
| Buyback Yield / Dilution | -571.35% | -374.79% | -98.24% | 56.93% | -15.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.